共 48 条
- [21] Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer EDITORIAL COMMENT JOURNAL OF UROLOGY, 2012, 188 (03): : 767 - 768
- [22] RISK OF ADVERSE PATHOLOGY AFTER DEFERRED PROSTATECTOMY FOR GRADE GROUP 1 AND 2 PROSTATE CANCER BEING MANAGED BY ACTIVE SURVEILLANCE JOURNAL OF UROLOGY, 2022, 207 (05): : E744 - E744
- [23] Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance EDITORIAL COMMENT JOURNAL OF UROLOGY, 2017, 198 (03): : 598 - 599
- [25] Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer EDITORIAL COMMENT JOURNAL OF UROLOGY, 2023, 210 (01): : 107 - 107
- [27] Re: Contemporary Use of Initial Active Surveillance among Men in Michigan with Low-Risk Prostate Cancer Editorial Comment JOURNAL OF UROLOGY, 2015, 193 (01): : 128 - 129
- [28] The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2016, 10 (11-12): : E424 - E427
- [30] Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores World Journal of Urology, 2015, 33 : 787 - 792